| scholarly article | Q13442814 |
| P2093 | author name string | Amine Bahi | |
| Mouza Al Ameri | |||
| Elyazia Al Maamari | |||
| Shamma Al Mansouri | |||
| P2860 | cites work | Urokinase-type plasminogen activator receptor (uPAR) as a promising new imaging target: potential clinical applications | Q26865306 |
| Plasticity-related serine proteases in the brain (review). | Q33543262 | ||
| The neurobiology of alcohol consumption and alcoholism: an integrative history | Q34378869 | ||
| Overexpression of urokinase-type plasminogen activator in transgenic mice is correlated with impaired learning | Q35160927 | ||
| Adenosine and glutamate signaling in neuron-glial interactions: implications in alcoholism and sleep disorders | Q35951700 | ||
| Drug dependence, synaptic plasticity, and tissue plasminogen activator. | Q36026364 | ||
| Control of the reinforcing effects of nicotine by associated environmental stimuli in animals and humans | Q36145119 | ||
| Neuroserpin | Q36250899 | ||
| Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. | Q36499294 | ||
| Interactive effects of methylphenidate and alcohol on discrimination, conditioned place preference and motor coordination in C57BL/6J mice | Q36539767 | ||
| A rational approach to the pharmacotherapy of alcohol dependence | Q36657736 | ||
| Global burden of disease from alcohol, illicit drugs and tobacco | Q36667173 | ||
| Individual differences in elevated plus-maze exploration predicted higher ethanol consumption and preference in outbred mice. | Q50537834 | ||
| Ghrelin knockout mice show decreased voluntary alcohol consumption and reduced ethanol-induced conditioned place preference. | Q50758437 | ||
| The selective metabotropic glutamate receptor 7 allosteric agonist AMN082 prevents reinstatement of extinguished ethanol-induced conditioned place preference in mice. | Q51822261 | ||
| Pharmacological modulation of mGluR7 with AMN082 and MMPIP exerts specific influences on alcohol consumption and preference in rats. | Q52298306 | ||
| Localization of urokinase-type plasminogen activator mRNA in the adult mouse brain | Q71284248 | ||
| Effects of synthetic urokinase inhibitors on local invasion and metastasis in a murine mammary tumor model | Q71711015 | ||
| Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator | Q72342448 | ||
| Maximum effect of urokinase plasminogen activator inhibitors in the control of invasion and metastasis of rat mammary cancer | Q73576437 | ||
| Inhibition of mammary tumor cell adhesion, migration, and invasion by the selective synthetic urokinase inhibitor B428 | Q77802582 | ||
| The circadian Per1 and Per2 genes influence alcohol intake, reinforcement, and blood alcohol levels | Q36901866 | ||
| The many spaces of uPAR: delivery of theranostic agents and nanobins to multiple tumor compartments through a single target | Q36997621 | ||
| Urokinase plasminogen activator receptor (uPAR) targeted nuclear imaging and radionuclide therapy | Q36997627 | ||
| Conditioned reinforcement and locomotor activating effects of caffeine and ethanol combinations in mice | Q37248707 | ||
| Endogenous modulators for drug dependence | Q37256242 | ||
| Integrative genetic analysis of alcohol dependence using the GeneNetwork Web resources | Q37386617 | ||
| The neurobiology of addictive disorders | Q37616113 | ||
| Breaking the loop: oxytocin as a potential treatment for drug addiction. | Q37971289 | ||
| Plasminogen activator inhibitor-1 in kidney pathology (Review). | Q38073673 | ||
| Using conditioned place preference to identify relapse prevention medications | Q38107338 | ||
| Impact of expression of the uPA system in sarcomas | Q38111811 | ||
| Involvement of urokinase-type plasminogen activator system in cancer: an overview | Q38189275 | ||
| Silencing urokinase in the ventral tegmental area in vivo induces changes in cocaine-induced hyperlocomotion | Q40241285 | ||
| Mechanisms of alcohol abuse and alcoholism in adolescents: a case for developing animal models | Q40593833 | ||
| Trends in place preference conditioning with a cross-indexed bibliography; 1957-1991. | Q40887711 | ||
| Prevention of breast cancer growth, invasion, and metastasis by antiestrogen tamoxifen alone or in combination with urokinase inhibitor B-428. | Q41093954 | ||
| Prevention of prostate-cancer metastasis in vivo by a novel synthetic inhibitor of urokinase-type plasminogen activator (uPA). | Q41260093 | ||
| Viral-mediated knockdown of mGluR7 in the nucleus accumbens mediates excessive alcohol drinking and increased ethanol-elicited conditioned place preference in rats | Q41967906 | ||
| Summary health statistics for U.S. adults: national health interview survey, 2012. | Q42219232 | ||
| Increased anxiety, voluntary alcohol consumption and ethanol-induced place preference in mice following chronic psychosocial stress | Q43761350 | ||
| Striatal modulation of BDNF expression using microRNA124a-expressing lentiviral vectors impairs ethanol-induced conditioned-place preference and voluntary alcohol consumption | Q43813771 | ||
| Ethanol consumption patterns and conditioned place preference in mice lacking preproenkephalin | Q44014492 | ||
| In vivo gene delivery of urokinase-type plasminogen activator with regulatable lentivirus induces behavioural changes in chronic cocaine administration | Q45195004 | ||
| Chronic psychosocial stress causes delayed extinction and exacerbates reinstatement of ethanol-induced conditioned place preference in mice | Q45227710 | ||
| Influence of the novel histamine H₃ receptor antagonist ST1283 on voluntary alcohol consumption and ethanol-induced place preference in mice. | Q46022094 | ||
| Effects of urokinase-type plasminogen activator in the acquisition, expression and reinstatement of cocaine-induced conditioned-place preference | Q46627257 | ||
| The role of tissue-type plasminogen activator system in amphetamine-induced conditional place preference extinction and reinstatement | Q46767430 | ||
| Transgenic mice overexpressing urokinase-type plasminogen activator in the brain exhibit reduced food consumption, body weight and size, and increased longevity | Q47313464 | ||
| Long-lived alphaMUPA transgenic mice exhibit pronounced circadian rhythms | Q48491862 | ||
| Overexpression of plasminogen activators in the nucleus accumbens enhances cocaine-, amphetamine- and morphine-induced reward and behavioral sensitization | Q48576876 | ||
| Involvement of nucleus accumbens dopamine D1 receptors in ethanol drinking, ethanol-induced conditioned place preference, and ethanol-induced psychomotor sensitization in mice | Q48725498 | ||
| Involvement of tissue plasminogen activator "tPA" in ethanol-induced locomotor sensitization and conditioned-place preference | Q48880988 | ||
| Elevated alcohol consumption in null mutant mice lacking 5-HT1B serotonin receptors | Q48937190 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1391-1403 | |
| P577 | publication date | 2014-09-16 | |
| P1433 | published in | Drug Design, Development and Therapy | Q2566724 |
| P1476 | title | Inhibition of urokinase plasminogen activator "uPA" activity alters ethanol consumption and conditioned place preference in mice | |
| P478 | volume | 8 |
Search more.